Hyunglok Chung, PhD, has found the Drosophila fruit fly a key partner in discovering ultra-rare and previously unknown diseases, as well as developing new treatments for already known maladies. Read more

Mitchell Syndrome patients and families hope for new treatments after raising $25,000

Four families from across the country are in Houston this week, hoping to find a treatment for a rare neurological disorder called Mitchell Syndrome. Just over 20 people in the world have been diagnosed with the genetic mutation so far and most of them have been children. Read more

First Ever Mitchell Syndrome Summit

Originally, it was just going to a small meet-up of Mitchell-Moms for friendship and support. But as plans came together, it became something more: The first ever Mitchell Syndrome Summit at Houston Methodist Hospital. Read more

This young man is coping with a rare disease that doesn’t have a name (nbcnews.com)

Mitchell Herndon has a disease so rare that there is no name for it. As one of only two known patients in the world, he grapples with a reality that sees him as a case study for doctors who are only beginning to learn about his condition. Watch video

Study reveals a novel biomarker and a potentially improved therapy for Multiple Sclerosis and related neurodegenerative disorders

New research finds sphingosine 1-Phosphate produced by the degradation of myelin results in neuroinflammation and drugs that reduce its level can reverse pathologies in animal models of MS. Read more

Dr. Hyunglok Chung announced as a winner of the 2021 Warren Alpert Distinguished Scholars Award

The Warren Alpert Foundation postdoctoral program was established 3 years ago to advanced neuroscience training as a bridge toward developing a career trajectory in academia, Industry, or governmental science. This highly competitive national program has been awarded to 5-7 individuals each year providing two years of support in a setting that permits independent scholarship to advance career development. Read more